Champ Resto Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Champ Resto Indonesia Tbk. trades at Rp224 (market cap 494B, 437.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Champ Resto Indonesia Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Champ Resto Indonesia Tbk. is more actively traded (437.2K versus 324K). Which is the better fit depends on your goals.
| ENAK | OBAT | |
|---|---|---|
Market Cap | 494B | 166.01B |
Volume | 437.2K | 324K |
Lot | 4.37K | 3.24K |
Turnover | 97.63M | 77.68M |
Average Price | 223.3 | 239.75 |
Value | 97.63M | 77.68M |
Indicative Equilibrium Price | 224 | 240 |
Indicative Equilibrium Volume | 10 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.
Read more on ENAK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →